摘要
目的探讨舒芬太尼复合罗哌卡因鞘内注射在阑尾切除术中对内脏牵拉反应抑制的临床意义。方法40例16～50岁急诊行阑尾切除术的患者随机分成二组，对照组：1％罗哌卡因15mg＋10％葡萄糖1ml；舒芬组：1％罗哌卡因15mg＋舒芬太尼5μg（0．5ml）＋20％葡萄糖0．5ml。对术中内脏牵拉反应，镇静二个方面进行评估。结果二组在年龄、体重、身高等比较差异均无统计学意义（P〉0．05）。在抑制内脏牵拉反应，镇静二个方面，舒芬组均优于对照组（P〈0．05）。舒芬组血压、心率和对照组比较差异无统计学意义（P〉0．05）。结论舒芬太尼复合罗哌卡因鞘内注射在阑尾切除术中对内脏的牵拉反应有明显的抑制。
Objective To discuss the safety and efficacy of intrathecal sufentanil combined with 0.6% ropivacaine in appendectomy. Methods 40 patients aged 16 - 50 yrs undergoing appendectomy were randomly assigned to two groups; 1% ropivacaine 15mg plus 10%GS1ml（A group） and 1% ropivacaine 15mg plus Sufentanil 5μg（0.5ml） plus 20%GS0.5ml（B group）. Two aspects, viscera traction action and sedation, were evaluated. Results Demographic data including age, body weight and height were similar among the two groups. So were blood pressure and heart rate （P〉0.05）. Treatment in group B was more effective in reducing visceral traction action and sedation than that in group A （P〈0.05）. Conclusion Intrathecal sufentanil combined with 0.6% ropivacaine can significantly reduce visceral traction action in patients undergoing appendectomy.
出处
《中国煤炭工业医学杂志》
2007年第2期136-137,共2页
Chinese Journal of Coal Industry Medicine
关键词
舒芬太尼
鞘内注射
脊髓
内脏牵拉反应
镇静
sufentanik
intrathecal injection, spinal
visceral traction
sedation
